Filter
194
Filtered Results: 194
Text search:
National
Pharmacovigilance
and
Medicines
Information
Center
Featured
Recommendations
25
New Publications
59
Language
Document type
No document type
109
Guidelines
30
Studies & Reports
29
Manuals
11
Strategic & Response Plan
7
Training Material
3
Situation Updates
3
Fact sheets
2
Countries / Regions
Rwanda
10
Nigeria
10
Kenya
9
Ethiopia
9
Namibia
8
India
8
Ghana
7
South Africa
6
Nepal
5
Cambodia
5
Liberia
5
Philippines
4
Latin America and the Carribbean
4
Tanzania
4
Eastern Europe
4
Zambia
4
Mozambique
3
Western and Central Europe
3
Russia
3
Ukraine
2
Sierra Leone
2
Malawi
2
Africa
2
Asia
2
West and Central Africa
2
South–East Asia Region
2
Bangladesh
2
Uganda
2
Botswana
2
Indonesia
2
Pakistan
2
Thailand
1
Lesotho
1
Gambia
1
Cameroon
1
Laos
1
Senegal
1
Afghanistan
1
Zimbabwe
1
Haiti
1
Jordan
1
Middle East and North Africa
1
Western Pacific Region
1
East and Southern Africa
1
Argentina
1
Sri Lanka
1
Georgia
1
Libya
1
Bhutan
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
34
Policies & Guidelines HIV & TB
28
Policies
26
Guidelines
17
Studies & Reports
9
NTDs & Others
6
TB
5
Statistics
4
Pharmacy & Technology
3
Communicable Diseases
2
Vaccine-preventable Diseases
2
Pharmaceutical Assessments
2
NCD
2
Women & Child Health
2
Capacity Building
2
General Guidelines
2
Leprosy
2
Helminthiasis
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
COVID-19
1
Pediatric cancer
1
Snakebites
1
Pediatrics
1
Countries
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Respiratory Infections
1
Immunization
1
Health Systems
1
Primary Health Care
1
Non-communicable Diseases
1
Malaria
1
Disease Prevention & Control
1
Key Resources
1
Toolboxes
Country specific
7
Rational use of Medicine
7
Immunization Guidelines
6
Clinical Guidelines
5
Supporting tools
4
Hospital Readiness/Essential Health Services
4
Traditional & Herbal Medicines
4
Pharmacovigilance
4
Clinical Aspects, Treatment & Prevention
3
Country Specific
3
Pharmacy Practice
3
General Guidelines for Rational Use
3
Drug resistant TB
3
Antiretroviral Treatment ART
3
Treatment & Prevention
2
Adults
2
Ethiopia
2
Studies
2
General
2
Infection Control General
2
Access & Strategy
2
Essential Medicines
2
Falsified & Substandard
2
Pharmaceutical Assessments
2
Reports & Studies
2
Eastern Europe & Central Asia
2
Kenya
2
Reports & Studies
2
SEAR (South-east Asia Region)
2
Eastern Europe and central Asia
2
Clinical Guidelines
1
Clinical Aspects
1
Prevention & Control
1
Vaccination
1
Children & Adolescents
1
WPRO (Western Pacific Region)
1
Influenza
1
Namibia
1
HIV
1
Rwanda
1
TB & Other Vulnerable Populations
1
Children
1
Georgia
1
Drug resistance
1
Country Guidelines
1
International
1
Prevention & Preparedness
1
Context & Facts, Travel Advice
1
Surveillance & Contact tracing
1
Training, others
1
Gender Aspects
1
Oxygen Therapy
1
TB/HIV
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
General documents One Health
1
Antimicrobial Resistance (AMR)
1
Non-communicable Diseases NCD
1
Heat
1
Capacity Building & Resources
1
Studies & Reports
1
Patient Safety
1
Overview, Studies & Reports
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
General Aspects
1
Regional Reports & Guidelines, others
1
Education of students & professionals
1
Research & Access
1
General Public
1
Clinical Guidelines
1
HIV service delivery
1
AmR (Region of Americas)
1
TB
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
6th edition
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues ...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
NEMLIST | Sixth Edition | February 2016
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
